Literature DB >> 28150184

Thrombotic thrombocytopenic purpura in a new onset lupus patient?

Nery Sablón González1, Noel Lorenzo2, Yanet Parodis1, Maria Belen Alonso Ortiz1, Melek Kechida3, Jose Carlos Rodriguez Perez1.   

Abstract

We are presenting a case of TTP with undetectable levels of ADAMTS 13 in a 39-year-old woman. Diagnosis of systemic lupus was evoked in the setting of thrombotic microangiopathy. The patient presented normal renal function but important neurological impairment. Treatment with daily plasmapheresis as well as Rituximab, cyclophosphamide as steroids was required to achieve clinical improvement.

Entities:  

Keywords:  Lupus; Microangiopathic hemolytic anemia; Thrombotic thrombocytopenic purpura

Mesh：

Substances：

Year:  2017        PMID： 28150184     DOI： 10.1007/s12026-017-8898-y

Source DB:  PubMed          Journal:  Immunol Res        ISSN： 0257-277X            Impact factor:   2.829


  14 in total

1.  Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias.

Authors:  Sarah L Allford; Beverley J Hunt; Peter Rose; Samuel J Machin
Journal:  Br J Haematol       Date:  2003-02       Impact factor: 6.998

2.  Pathogenesis and treatment of acquired idiopathic thrombotic thrombocytopenic purpura.

Authors:  Flora Peyvandi; Roberta Palla; Luca A Lotta
Journal:  Haematologica       Date:  2010-09       Impact factor: 9.941

Review 3.  Thrombotic thrombocytopenic purpura: a moving target.

Authors:  J Evan Sadler
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

Review 4.  The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura.

Authors:  Wendy Lim; Sara K Vesely; James N George
Journal:  Blood       Date:  2015-01-08       Impact factor: 22.113

Review 5.  [Thrombotic thrombocytopenic purpura].

Authors:  Javier de la Rubia; Enric Contreras; Julio Del Río-Garma
Journal:  Med Clin (Barc)       Date:  2010-04-24       Impact factor: 1.725

Review 6.  Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus.

Authors:  G Nesher; V E Hanna; T L Moore; M Hersh; T G Osborn
Journal:  Semin Arthritis Rheum       Date:  1994-12       Impact factor: 5.532

7.  Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006.

Authors:  Loan Nguyen; Xiaoning Li; Deanna Duvall; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Transfusion       Date:  2007-11-19       Impact factor: 3.157

8.  A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus.

Authors:  Pagalavan Letchumanan; Heng-Joo Ng; Lai-Heng Lee; Julian Thumboo
Journal:  Rheumatology (Oxford)       Date:  2009-02-06       Impact factor: 7.580

9.  Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008.

Authors:  Yoshihiro Fujimura; Masanori Matsumoto
Journal:  Intern Med       Date:  2010-01-01       Impact factor: 1.271

10.  Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura.

Authors:  O Devinsky; C K Petito; D R Alonso
Journal:  Ann Neurol       Date:  1988-04       Impact factor: 10.422
View more
  2 in total

1.  Systemic Lupus Erythematosus Induced by Autoimmune/ Inflammatory Syndrome Induced by Adjuvants. Is it Possible? Long-Term Follow-up and Literature Review.

Authors:  Agata Sebastian; Aleksandra Butrym; Maria Misterska Skóra; Arkadiusz Chlebicki; Grzegorz Mazur; Piotr Wiland
Journal:  Arch Rheumatol       Date:  2018-01-15       Impact factor: 1.472

Review 2.  Upfront rituximab therapy for thrombotic thrombocytopenic purpura in systemic lupus erythematosus: a case-based review.

Authors:  Tomoyuki Mutoh; Keiichi Ohashi; Taichi Nagai; Akira Sugiura; Masataka Kudo; Hiroshi Fujii
Journal:  Rheumatol Int       Date:  2022-08-12       Impact factor: 3.580
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.